Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank33
3Y CAGR-22.2%
5Y CAGR-50.0%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
-22.2%/yr
Annual compound
5Y CAGR
-50.0%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 13.51% |
| 2024 | 43.17% |
| 2023 | -7.37% |
| 2022 | 28.70% |
| 2021 | 117.51% |
| 2020 | 434.35% |
| 2019 | 0.00% |